Business Expansion
on Kobe's Port Island
349
companies
as of March 31, 2025
Companies are divided into categories by their major business field on Kobe Port Island. In the case they have other business fields, it is shown in the minor field.» List of KBIC companies(PDF)
Entities are classified mainly by their business activities in the South area of KOBE Port Island.
1～ 9of Results 9
Re-search in Business sectorMajor field
Minor field
Company name
Business outline
Entities are classified mainly by their business activities in the South area of KOBE Port Island.
1～ 9of Results 9
Re-search in LocationMajor field
Miner field
Company name
Business outline
You can select the initial.
1～ 9of Results 9
Re-search in InitialMajor field
Miner field
Company name
Business outline
Major field： Cosmetic
| Address： | Room 609, Kobe International Business Center, 5-5-2 Minatojima-Minamimachi, Chuo-ku, Kobe City, 650-0057, Japan （Contact Person Ning XIA） | ||
|---|---|---|---|
| TEL： | 0081-78-381-9640 | FAX： | 0081-78-381-9730 |
| Web site： | https://offandrelax.jp/ | E-mail： | info@offandrelax.jp |
Major field： Material and Chemical Products
Miner field： Production of Research Equipment
Major field： Material and Chemical Products
Providing processing technologies and functional films for packaging, industrial use, optical film for FPD, wood building materials, etc.
| Address： | 1515 Nakazu-cho, Marugame, Kagawa 763-8508 Japan （Contact Person JUNPEI YUGICHI (R&D Center)） | ||
|---|---|---|---|
| TEL： | +81-877-56-1260 | FAX： | +81-877-56-1263 |
| Web site： | http://www.okr-ind.co.jp | E-mail： | j-yuguchi@okr-ind.co.jp |
Major field： Drug Discovery
Miner field： Production of Drugs and Quasi Drugs
Miner field： Diagnostic Agent and Device
Unique drug discovery and development standing on virology.
We do our business activities of pharmaceutical and diagnostic businesses together under the concept of "drug discovery and development standing on virology".
In pharmaceutical business, we will develop safe, effective and novel drug targeting "cancer and serious infectious diseases" that can be a new option of therapy for such intractable diseases. In diagnostic business, we will provide new inspection services using genetic modification technology for virus that is our platform technology. We will establish multiple earning structures based on the achievement by the activities above, and accelerate the development of current new drug candidates under more stable management environment. In addition, we will actively seek or obtain seeds for new drugs to continue and expand our business for the future.
| Address： | 4-1-28 Toranomon, Minato-ku, Tokyo, 105-0001, JAPAN （Contact Person Corporate Planning Department） | ||
|---|---|---|---|
| TEL： | +81-3-5472-1578 | FAX： | +81-3-5472-1488 |
| Web site： | https://www.oncolys.com | E-mail： | oncolys_information@oncolys.com |
Major field： Production of Drugs and Quasi Drugs
Miner field： Drug Discovery
Major field： Drug Discovery
Major field： Assisting Businesses, Rental Laboratories and Offices
Major field： Experimental Animals
Miner field： Regenerative Medicine
Miner field： Contract Research
Major field： Production of Drugs and Quasi Drugs
Miner field： Drug Discovery
Miner field： Cosmetic